CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Aug. 12, 2020—Siemens Healthineers received FDA emergency use authorization for the SARS-CoV-2 IgG antibody test. It is the first antibody test authorized with a semiquantitative detection claim.
The test offers a positive or negative result for IgG antibodies and reports a numerical result expressed as index value. “With this numerical value, clinicians can establish a baseline and be better equipped to assess changes of an individual’s immune response to the SARS-CoV-2 virus,” the company said in a statement. “Comparison of numerical results will help determine how SARS-CoV-2 antibodies develop in an individual and persist over time.”
Pages: 1 2